(Emory University) Researchers at 17 medical centers soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of an NIH-funded, randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people beginning in March, 2010. An earlier trial in 100 patients found that giving progesterone to trauma victims shortly after a brain injury appears to be safe and may reduce the risk of death and long-term disability.
Further information:
Related posts:
- Progesterone May Help Treat Traumatic Brain Injury Patients, Phase III Trial To Start
- What Is Traumatic Brain Injury (TBI)? What Causes Traumatic Brain Injury?
- Mild traumatic brain injury, not so mild after all
- Brain injury support service marks 10 years
- If your loved one has suffered a serious brain injury, who do you need to talk to?

Posted in